These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19583480)

  • 21. Propylthiouracil-induced cutaneous vasculitis.
    Yarman S; Sandalci O; Tanakol R; Azizlerli H; Oguz H; Alagöl F
    Int J Clin Pharmacol Ther; 1997 Jul; 35(7):282-6. PubMed ID: 9247841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric Graves' disease: controversies in management.
    Rivkees SA
    Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithyroid drugs in practice.
    Vanderlaan WP
    Mayo Clin Proc; 1972 Dec; 47(12):962-5. PubMed ID: 4117991
    [No Abstract]   [Full Text] [Related]  

  • 25. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
    Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
    J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithyroid agents and embryopathies].
    Bournaud C; Orgiazzi J
    Ann Endocrinol (Paris); 2003 Nov; 64(5 Pt 1):366-9. PubMed ID: 15067747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current trends in antithyroid drug treatment of Graves' disease.
    Okosieme OE; Lazarus JH
    Expert Opin Pharmacother; 2016 Oct; 17(15):2005-17. PubMed ID: 27615550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of time to remission and treatment failure in patients with Graves' disease treated with propylthiouracil.
    Cinemre H; Bilir C; Gokosmanoglu F; Akdemir N; Erdogmus B; Buyukkaya R
    Clin Invest Med; 2009 Jun; 32(3):E199-205. PubMed ID: 19480735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Liver Failure: A Potential Complication of Antithyroid Medication Use.
    Chou C; Wong RJ; Higgins JP; Perumpail RB; Ahmed A
    Dig Dis Sci; 2015 Jul; 60(7):1924-7. PubMed ID: 25366145
    [No Abstract]   [Full Text] [Related]  

  • 34. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
    Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
    Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
    Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
    Toderian AB; Lawson ML
    Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
    Okamura K; Sato K; Fujikawa M; Bandai S; Ikenoue H; Kitazono T
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3995-4002. PubMed ID: 25144628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.
    Emiliano AB; Governale L; Parks M; Cooper DS
    J Clin Endocrinol Metab; 2010 May; 95(5):2227-33. PubMed ID: 20335447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.